Literature DB >> 12202651

Treatment of advanced non-small-cell lung cancer with two-drug combinations.

Paul A Bunn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12202651     DOI： 10.1200/JCO.2002.20.17.3565

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer.

Authors:  Mahavir Chougule; Apurva R Patel; Pratik Sachdeva; Tanise Jackson; Mandip Singh
Journal:  Lung Cancer       Date:  2010-07-31       Impact factor: 5.705

Review 2.  Targeting the epidermal growth factor receptor in the treatment of colorectal cancer: state of the art.

Authors:  Robert B Diasio; Jeanne Fourie
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).

Authors:  Jacques De Grève; Jan Van Meerbeeck; Johan F Vansteenkiste; Lore Decoster; Anne-Pascale Meert; Peter Vuylsteke; Christian Focan; Jean-Luc Canon; Yves Humblet; Guy Berchem; Benoit Colinet; Danny Galdermans; Lionel Bosquée; Joanna Vermeij; Alex Dewaele; Caroline Geers; Denis Schallier; Erik Teugels
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.